JPMORGAN CHASE & CO - SUNESIS PHARMACEUTICALS INC ownership

SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 2 filers reported holding SUNESIS PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of SUNESIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$25,000
+4.2%
45,1120.0%0.00%
Q1 2016$24,000
-36.8%
45,112
+7.4%
0.00%
Q4 2015$38,000
+100.0%
41,999
+82.2%
0.00%
Q3 2015$19,000
-93.7%
23,047
-77.0%
0.00%
Q2 2015$301,000
+230.8%
100,077
+170.1%
0.00%
Q1 2015$91,000
+85.7%
37,055
+93.9%
0.00%
Q4 2014$49,00019,1060.00%
Other shareholders
SUNESIS PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Lamond Capital Partners LLC 1,320,000$9,425,00010.46%
RA Capital Management 4,869,261$34,767,0004.11%
GREAT POINT PARTNERS LLC 400,000$2,856,0001.23%
Healthcare Value Capital, LLC 100,000$714,0000.69%
DSC Advisors, L.P. 175,000$1,250,0000.63%
Quantitative Systematic Strategies LLC 107,416$803,0000.47%
Visium Asset Management, LP 4,093,890$29,230,0000.43%
Rhenman & Partners Asset Management AB 201,171$1,436,0000.42%
EAM Investors, LLC 277,807$1,984,0000.40%
ESSEX INVESTMENT MANAGEMENT CO LLC 354,861$2,534,0000.39%
View complete list of SUNESIS PHARMACEUTICALS INC shareholders